Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | THRB | P10828 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14997611 | 0.89 | ADORA3 (0.30) | — | |
| SCHEMBL6987435 | 0.86 | THRB (0.35) | THRB | |
| SCHEMBL17903044 | 0.83 | THRB (0.34) | THRB | |
| SCHEMBL17903045 | 0.81 | THRB (0.33) | THRB | |
| SCHEMBL13828364 | 0.80 | THRB (0.31) | THRB | |
| SCHEMBL12743131 | 0.80 | ADORA3 (0.33) | — | |
| SCHEMBL17167522 | 0.80 | — | — | |
| SCHEMBL17917549 | 0.80 | — | — | |
| SCHEMBL24621700 | 0.79 | ADORA3 (0.33) | — | |
| SCHEMBL17167184 | 0.79 | ADORA3 (0.33) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120122949-A1 | ULTRA-HIGH STRENGTH INJECTABLE HYDROGEL AND PROCESS FOR PRODUCING THE SAME | THE UNIVERSITY OF TOKYO (JP) | 2012-05-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120122949-A1 | ULTRA-HIGH STRENGTH INJECTABLE HYDROGEL AND PROCESS FOR PRODUCING THE SAME | CD44, IGFBP4, IL4 | THRB 3889/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.